Prof. Dr. Andreas Mackensen

Lehrstuhl für Innere Medizin V

Control of PD-L1 expression in CLL-cells by stromal triggering of the Notch-c-Myc-EZH2 oncogenic signaling axis (2021) Böttcher M, Bruns H, Völkl S, Lu J, Chartomatsidou E, Papakonstantinou N, Mentz K, et al. Journal article Triton X-114 and Amine-Based Wash Strategy Reduces Lipopolysaccharides to FDA Limit and Achieves Purer, More Potent Recombinant Immunotoxin (2021) George R, Gsottberger F, Ammon AM, Wendland K, Mellenthin L, Mackensen A, Müller F Journal article Sorafenib or placebo in patients with newly diagnosed acute myeloid leukaemia: long-term follow-up of the randomized controlled SORAML trial (2021) Röllig C, Serve H, Noppeney R, Hanoun M, Krug U, Baldus CD, Brandts CH, et al. Journal article Protein kinase C-β-dependent changes in the glucose metabolism of bone marrow stromal cells of chronic lymphocytic leukemia (2021) Von Heydebrand F, Fuchs M, Kunz M, Kremer A, Oostendorp RAJ, Wilke J, Leitges M, et al. Journal article Hydrogen-peroxide synthesis and LDL-uptake controls immunosuppressive properties in monocyte-derived dendritic cells (2021) Menzner AK, Rottmar T, Bosch JJ, Mougiakakos D, Mackensen A, Resheq Y, Völkl S Journal article Linking Immunoevasion and Metabolic Reprogramming in B-Cell–Derived Lymphomas (2020) Böttcher M, Stoll A, Mackensen A, Mougiakakos D, Baur R Journal article, Review article The Oncometabolite 5′-Deoxy-5′-Methylthioadenosine Blocks Multiple Signaling Pathways of NK Cell Activation (2020) Jacobs B, Schlögl S, Strobl C, Stoll A, Mougiakakos D, Malmberg KJ, Mackensen A, et al. Journal article Immune cell regulation by vitamin D-3 during allogeneic hematopoietic stem cell transplantation (HSCT) (2020) Flamann C, Zeun J, Kremer A, Peter K, Kreutz M, Büttner-Herold M, Kellner C, et al. Conference contribution Stroma cells promote a S100A8/A9(high) subset of chemoresistant AML blasts with distinct metabolic features in a Jak/STAT-dependent manner (2020) Böttcher M, Panagiotidis K, Mentz K, Popp S, Geyh S, Jaeger P, Schroeder T, et al. Conference contribution A murine, myc-driven lymphoma model expressing human CD22 enables testing of targeted therapies and their effects on tumor immune microenvironment (2020) Gsottberger F, Brandl C, Petkovic S, Emmerich C, Nitschke L, Mackensen A, Müller F Conference contribution